Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

Remunity 2.0 Pump for Remodulin (treprostinil) Injection

K-Number: K241736 · 2025-01-16

ApplicantDeka Research and Development Corp.
Decision Date2025-01-16
Product CodeFRN
Advisory CommitteeHO
DecisionSubstantially Equivalent

Device Summary

Remunity 2.0 Pump for Remodulin (treprostinil) Injection is the device name listed in this FDA 510(k) record. The listed applicant is Deka Research and Development Corp.. It received FDA 510(k) clearance on 2025-01-16 under 510(k) number K241736. The device is classified under product code FRN. It was reviewed by the HO advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the Remunity 2.0 Pump for Remodulin (treprostinil) Injection?

Remunity 2.0 Pump for Remodulin (treprostinil) Injection is a medical device that received FDA 510(k) clearance on 2025-01-16. The listed applicant is Deka Research and Development Corp.. The 510(k) number is K241736.

When did Remunity 2.0 Pump for Remodulin (treprostinil) Injection receive FDA 510(k) clearance?

Remunity 2.0 Pump for Remodulin (treprostinil) Injection received FDA 510(k) clearance on 2025-01-16, under 510(k) number K241736.

Who is the listed applicant for Remunity 2.0 Pump for Remodulin (treprostinil) Injection?

The FDA 510(k) record lists Deka Research and Development Corp. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for Remunity 2.0 Pump for Remodulin (treprostinil) Injection?

The FDA product code for Remunity 2.0 Pump for Remodulin (treprostinil) Injection is FRN.

Related Clinical Trials

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

NCT06853990Innovative Automated Insulin Delivery System for Type 2 DiabetesCOMPLETED

Other records listing Deka Research and Development Corp. as applicant

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K261672twiist Automated Insulin Delivery (AID) SystemK261530iiSure Infusion SetK243841Sparta Infusion Set for InsulinK242693DEKA Infusion System, DEKA Administration SetK240920HemoCare Bicarbonate Concentrate Set (BCS)K233557HemoCare Hemodialysis System

View all 14 devices →

Related Devices (Code: FRN)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K253703RemunityPRO+ Pump for Remodulin® (treprostinil) InjectionDeka R&D CorpK252015FreedomEdge Infusion System; High-Flo SubQ Needle Set; Precision Flow Rate TubingKoru Medical Systems, Inc.K251640SIGMA Spectrum Infusion Pump with Master Drug LibraryBaxter Healthcare CorporationK251636Spectrum IQ Infusion System with Dose IQ Safety Software (3570009)Baxter Healthcare CorporationK242752MRidium 3870 MRI Infusion Pump System (3870)Iradimed CorporationK243855BD Alaris Infusion System with Guardrails Suite MXCarefusion 303, Inc.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑